FRA:2U3 - Deutsche Boerse Ag - CH0432492467 - Common Stock - Currency: EUR
FRA:2U3 (6/19/2025, 7:00:00 PM)
74.16
+0.8 (+1.09%)
The current stock price of 2U3.DE is 74.16 EUR. In the past month the price decreased by -3.24%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1EL.MI | ESSILORLUXOTTICA | 35.57 | 110.49B | ||
EL.PA | ESSILORLUXOTTICA | 35.5 | 110.28B | ||
ESL.DE | ESSILORLUXOTTICA | 35.46 | 110.17B | ||
CBHD.DE | COLOPLAST-B | 29.43 | 17.20B | ||
GENT.OL | GENTIAN DIAGNOSTICS ASA | 19.16 | 919.03M | ||
GBT.PA | GUERBET | 17.28 | 277.45M | ||
ALCJ.PA | CROSSJECT | N/A | 83.21M | ||
PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 57.29M | ||
AFME.PA | AFFLUENT MEDICAL SA | N/A | 53.71M | ||
SVS.MI | SVAS BIOSANA SPA | 7.78 | 44.46M |
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,599 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.
ALCON INC
Rue Louis d'Affry 6
Fribourg FRIBOURG CH
Employees: 25599
Phone: 41589112222
The current stock price of 2U3.DE is 74.16 EUR. The price increased by 1.09% in the last trading session.
The exchange symbol of ALCON INC is 2U3 and it is listed on the Deutsche Boerse Ag exchange.
2U3.DE stock is listed on the Deutsche Boerse Ag exchange.
22 analysts have analysed 2U3.DE and the average price target is 99.34 EUR. This implies a price increase of 33.95% is expected in the next year compared to the current price of 74.16. Check the ALCON INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ALCON INC (2U3.DE) has a market capitalization of 37.06B EUR. This makes 2U3.DE a Large Cap stock.
ALCON INC (2U3.DE) currently has 25599 employees.
ALCON INC (2U3.DE) has a support level at 74.15 and a resistance level at 75.59. Check the full technical report for a detailed analysis of 2U3.DE support and resistance levels.
The Revenue of ALCON INC (2U3.DE) is expected to grow by 5.62% in the next year. Check the estimates tab for more information on the 2U3.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALCON INC (2U3.DE) has a dividend yield of 0.39%. The yearly dividend amount is currently 0.23. Check the full fundamental report for a detailed analysis of 2U3.DE dividend history, reliability and sustainability.
ALCON INC (2U3.DE) will report earnings on 2025-08-19, after the market close.
The PE ratio for ALCON INC (2U3.DE) is 28.41. This is based on the reported non-GAAP earnings per share of 2.61 and the current share price of 74.16 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 2U3.DE.
ChartMill assigns a technical rating of 3 / 10 to 2U3.DE.
ChartMill assigns a fundamental rating of 5 / 10 to 2U3.DE. 2U3.DE has an average financial health and profitability rating.
Over the last trailing twelve months 2U3.DE reported a non-GAAP Earnings per Share(EPS) of 2.61. The EPS increased by 6.38% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 11.28% | ||
ROA | 3.61% | ||
ROE | 5.09% | ||
Debt/Equity | 0.23 |
ChartMill assigns a Buy % Consensus number of 81% to 2U3.DE. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 8.02% and a revenue growth 5.62% for 2U3.DE